Blood screening for influenza

Emerging Infectious Diseases

Volumn 13, Issue 7, 2007, Pages 1081-1083

  Hourfar, Michael Kai ^a   Themann, Anna ^a   Eickmann, Markus ^b   Puthavathana, Pilaipan ^c   Laue, Thomas ^d   Seifried, Erhard ^a   Schmidt, Michael ^a,e  

^a Institute Springe   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c MAHIDOL UNIVERSITY   (Thailand)

^d QIAGEN GMBH   (Germany)

^e GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; BLOOD SAMPLING; HUMAN; INFLUENZA; INFLUENZA VIRUS; NUCLEIC ACID AMPLIFICATION; SENSITIVITY AND SPECIFICITY;

EID: 34447251928     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1307.060861     Document Type: Article

References (15)

1. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12:9-14.
2. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P,. et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005;352:333-40.
3. Mounier-Jack S, Coker RJ. How prepared is Europe for pandemic influenza? Analysis of national plans. Lancet. 2006;367:1405-11.
4. Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet. 1999;353:359-63.
5. Schmidt M, Brixner V, Ruster B, Hourfar MK, Drosten C, Preiser W, Seifried E, Roth WK, et al. NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion. 2004;44:470-5.
6. Puthavathana P, Auewarakul P, Charoenying PC, Sangsiriwut K, Pooruk P, Boonnak K, et al. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand J Gen Virol. 2005;86:423-33.
7. Yoshikawa T, Matsuo K, Matsuo K, Suzuki Y, Nomoto A, Tamura S, et al. Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice. J Gen Virol. 2004;85:2339-46.
8. AuBuchon JP. Birkmeyer JD, Busch MP. Safety of the blood supply in the United States: opportunities and controversies. Ann Intern Med. 1997;127:904-9.
9. Roth WK, Weber M, Buhr S, Drosten C, Weichert W, Sireis W, et al. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion. 2002;42:862-8.
10. Uphoff H, Cohen JM, Fleming D, Noone A. Harmonisation of national influenza surveillance morbidity data from EISS: a simple index. Euro Surveill. 2003;8:156-64.
11. Mounts AW, Kwong H, Izurieta HS, Ho Y, Au T, Lee M, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis. 1999;180:505-8.
12. Centers for Disease Control and Prevention. Cases of influenza A (H5N1) - Thailand, 2004. MMWR Morb Mortal Wkly Rep. 2004;53:100-3.
13. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. In vivo induction of apoptosis by influenza virus. J Gen Virol. 1995;76:2869-73.
14. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y. Viremia induced by influenza virus. Microb Pathog. 1995;19:237-44.
15. Chutinimitkul S, Bhattarakosol P, Srisuratanon S, Eiamudomkan A, Kongsomboon K, Damrongwatanapokin S, et al. H5N1 influenza A virus and infected human plasma. Emerg Infect Dis. 2006;12:1041-3. 1084-1086